Searchable abstracts of presentations at key conferences on calcified tissues

ba0002p162 | (1) | ICCBH2013

Low bone mass and fractures in young patients with chronic diseases

Bianchi Maria Luisa , Vai Silvia , Colombo Carla , Corona Fabrizia , Ghio Luciana , Morandi Lucia , Nebbia Gabriella

We performed a prospective study on 440 young patients (aged 3–20 years), affected by various chronic diseases (cystic fibrosis; juvenile idiopathic arthritis; nephrotic syndrome; systemic lupus erythematosus; Duchenne muscular dystrophy; autoimmune hepatitis; transplants; etc.), with periodical bone mineral density (BMD) evaluations with DXA, for 3–14 years (7.8±6.2).266 patients were on long-term treatment with glucocorticoids (GCs); amo...

ba0002p187 | (1) | ICCBH2013

Juvenile idiopathic osteoporosis responsive to intravenous alendronate

Guagnelli Miguel Angel , Yeste Diego , Clemente Maria , Garrido Marta , Carrascosa Antonio

Background: Osteoporosis in otherwise healthy children demands thorough study as it may be the first manifestation of an occult illness. When other diseases can be ruled out, juvenile idiopathic osteoporosis (JIO) is the purported diagnosis.PresentationWe report the case of an 8-year -old boy with no personal or family history of chronic disease who presented with sudden ankle pain unrelated to trauma and not responsive to rest and...

ba0002p191 | (1) | ICCBH2013

Long-term follow-up in Stuve–Wiedemann syndrome: a case report

Sabrina Buonuomo Paola , Macchiaiolo Marina , Cambiaso Paola , Capolino Rossella , Digilio Maria Cristina , Andrea Bartuli

Background: Stuve–Wiedemann syndrome (SWS, OMIM 601559) is a severe autosomal recessive condition characterized by bowing of the lower limbs with cortical thickening, wide metaphyses, abnormal trabecular pattern and camptodactyly. Additional features include dysautonomia symptoms with temperature instability, respiratory distress and sucking/swallowing difficulties in the first months of life.Most SWS cases do not survive beyond the first y...

ba0003oc2.5 | Osteoporosis epidemiology | ECTS2014

IGFBP1 as a predictor of hip fractures

Lundin Hans , Saaf Maria , Strender Lars-Erik , Nyren Sven , Johansson Sven-Erik , Salminen Helena

Insulin-like growth factor 1 (IGF-1) is known to be a predictor of future osteoporotic fractures. Insulin-like growth factor binding protein 1 (IGFBP1) regulates the bioavailability of IGF-1 and thus in reason IGFBP1 also could be a fracture predictor. To our knowledge there are no previous studies published on the relation between the serum concentration of IGFBP1 and fractures.This is a population-based prospective cohort study on 351 Swedish women age...

ba0003pp98 | Cancer and bone: basic, translational and clinical | ECTS2014

Biological markers of aggressive giant cell tumour of bone: an immunohistochemical study

Quattrini Irene , Pazzaglia Laura , Conti Amalia , Novello Chiara , Ferrari Cristina , Benassi Maria Serena

Giant cell tumour of bone (GCTb) is an osteolytic neoplasia with tendency to local recurrence (10–25%), while metastases or malignant transformation are described in 1–4% of cases.It is composed by three distinct populations that cross-talk each other generating unbalance in bone remodeling and activation of NF-kB signaling pathway.To identify new candidate biological markers useful for improving clinical management of GC...

ba0003pp99 | Cancer and bone: basic, translational and clinical | ECTS2014

Changes in bone mineral density and biochemical markers of bone turnover in postmenopausal women with breast cancer initiating aromatase inhibitors therapy

Luchavova Maria , Zimovjanova Martina , Zikan Vit , Pribylova Jana , Cabinakova Michaela , Petruzelka Lubos

Postmenopausal women with early stage hormone-receptor-positive breast cancer (EBC) are standardly treated with aromatase inhibitors (AIs). However, one side-effect of AIs treatment is a decrease in bone mineral density (BMD) and an increased risk of fracture. The objectives of this study were to examine: i) changes in bone formation (N-terminal propeptide of type I procollagen; PINP) and bone resorption (cross-linked C-telopeptides of bone type I collagen; CTX) markers, as we...

ba0003pp138 | Cell biology: osteoblasts and bone formation | ECTS2014

Metabolism and synthesis activity of calvaria osteoblasts from offspring of rats treated with caffeine during pregnancy

Sena Reis Amanda Maria , Ribeiro Lorena Gabriela Rocha , de Melo Ocarino Natalia , Serakides Rogeria

Caffeine is a methylxanthine found in many foods and is widely consumed by the human population. Therefore, its effects and mechanisms in various tissues have been widely studied. Various bone abnormalities have been observed in fetuses from rats treated with caffeine. But the genesis of these abnormalities is not known. The objective of this study was to verify the metabolism and activity of calvaria osteoblasts from offspring of rats treated with caffeine during pregnancy. T...

ba0003pp203 | Muscle, physical activity and bone | ECTS2014

Sarcopenic obesity worsens bone strength: hip strength analysis in post-menopausal women

Moretti Antimo , Giamattei Maria Teresa , de Sire Alessandro , Cannaviello Giovanni , Gimigliano Francesca , Gimigliano Raffaele , Iolascon Giovanni

Background: Among body composition phenotypes there is no consensus on definition and consequences of sarcopenic obese phenotype. The recommended method to quantify the muscle mass is the dual energy X-ray absorptiometry (DXA), based on measurement of total fat mass and appendicular lean mass. A high BMI may provide a great bone mineral density (BMD) in many individuals, but it does not guarantee optimal bone strength. The aim of our study is to investigate the influence of sa...

ba0003pp206 | Muscle, physical activity and bone | ECTS2014

Influence of sarcopenic obesity on osteoporosis and vertebral fragility fractures in post-menopausal women

Moretti Antimo , Giamattei Maria Teresa , de Sire Alessandro , Cannaviello Giovanni , Gimigliano Francesca , Iolascon Giovanni

Background: Sarcopenic obesity is usually defined by the combination of sarcopenia and obesity but there is not a standard definition yet. The recommended method for the quantification of muscle mass is dual energy X-ray absorptiometry (DXA), based on assessment of total fat mass and appendicular lean mass. Low Body Mass Index (BMI) used to be considered as a risk factor for fragility fracture. However, recent evidences have demonstrated a correlation between BMI and vertebral...

ba0003pp272 | Osteoporosis: pathophysiology and epidemiology | ECTS2014

Serum 25-hydroxyvitamin D levels of healthy adult women in Greece

Grigoriou Efi , Trovas George , Dontas Ismini , Papaioannou Nikolaos , Stathopoulou Maria , Dedoussis George

Objective: The objective of this observational cross-sectional study is to identify the prevalence of vitamin D deficiency in healthy women in Greece, as reflected by the levels of 25-hydroxyvitamin D (25(OH)D), since recent data indicate that vitamin D deficiency can be common in countries previously considered as low risk (e.g. Mediterranean countries).Materials and methods: A population of 840 community dwelling women was recruited at the health promo...